Cover Image
Market Research Report

The Royalty Rate Report 2016

Published by IMS World Publications Ltd. Product code 230265
Published Content info
Delivery time: 1-2 business days
Not Available
Back to Top
The Royalty Rate Report 2016
Published: July 25, 2016 Content info:

This publication has been discontinued on November 23, 2017.


Key insights into the industry's views on royalty rates and their impact in determining the value of a deal.


The Royalty Rate Report is the definitive guide for the industry and provides in-depth analysis of one of the most important but elusive components of a biopharma deal - the royalty rate.

Key Benefits

  • Gain opinions and advice from leading industry dealmakers who share their thoughts on royalty rates
  • Receive guidance on the best methodologies to use including benchmarking and advanced valuation techniques when calculating royalty rates for vital decision making
  • Understand the differences in perception of value between biotechnology companies and pharmaceutical companies and how that impacts the value of a deal
  • Review actual royalty rate data supported by case histories and be better informed before negotiating your next deal
  • Access to a comprehensive appendix includes the PharmaDeals' industry survey and a listing of all royalty reporting deals from the last ten years


  • One year subscription to the report published on the interactive online IMS Syndicated Analytics Library
  • IMS Syndicated Analytics Library offers full searchability including cut and create your own report, export tables, figures and whole chapters into Excel, PowerPoint and Word
  • Nine language automatic translation - choose to view report in French, German, Chinese, Italian, Spanish, Japanese, Portuguese, Korean or Russian
Table of Contents

Table of Contents

  • First hand insight on royalty rates from deal-makers via our PharmaDeals survey
  • A historical overview of royalties, their relevance to the biopharma industry and the psychology of royalty structures
  • Introduction to methods for calculating useful financial data missing from the public domain - essential for dealmakers in benchmarking and determining value in a deal and its relationship with future royalty streams
  • Thought leadership on determining royalty rates including the concept of effective royalties in the analysis of deal structures. Also how to calculate royalty rates in pharmaceutical deals supported by key opinion leader insight
  • A detailed presentation of key methodologies - benchmarking and expected net present value - used in calculating royalty rates
  • Market data and current trends in royalty rate disclosure by development phase, by indication and by the top pharmaceutical companies
  • Industry perception of royalties including a review of the literature, discussion on tiered royalty rates and critical analysis of the results of current and previous PharmaDeals Royalty Rates Surveys
Back to Top